Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services (CMS), delivered a cautionary statement on Wednesday regarding the potential short-term cost inflation in healthcare due to the widespread adoption of artificial intelligence, while emphasizing its long-term promise for significant cost savings. His remarks were made during a speech at Oracle’s annual health and life sciences summit in Orlando, Florida, where industry leaders gathered to discuss technological advancements in the sector.
Short-Term Cost Inflation From AI
Oz highlighted that AI will “turbocharge” medical billing systems, significantly enhancing providers’ ability to bill insurers for additional medical conditions more effectively. While this technology holds promise for reducing administrative burdens and improving clinical documentation accuracy, researchers have observed that AI-driven coding innovations are already contributing to higher healthcare spending levels across the system. A recent full study conducted by the Blue Cross Blue Shield Association revealed that increased billing activity has added nearly $1 billion in costs between 2023 and 2025, raising serious concerns about AI’s role in accelerating overall healthcare expenses.
CMS Initiatives and ACOs
The CMS has taken proactive steps by establishing a dedicated office for health technology and AI implementation, while also integrating artificial intelligence into its anti-fraud efforts to detect and prevent fraudulent billing practices. Oz emphasized that artificial intelligence remains essential for combating disease, stating, “I guarantee you we will lose lives if we don’t use AI in the day-to-day trench warfare of fighting disease in America.” To achieve these long-term savings, the agency is placing significant reliance on accountable care organizations, or ACOs, which are designed to incentivize providers to improve health outcomes rather than simply increase service volume. CMS initiatives aim to expand ACO participation throughout the healthcare system, claiming that such models save billions for Medicare and drive down spending.
Criticism of the ACO model centers primarily on financial risks for providers and the addition of new administrative layers to the healthcare delivery system. Critics argue that if providers fail to reduce spending while maintaining high standards of care quality, they face financial risks. The strategic shift from traditional fee-for-service billing models to outcome-based payment structures represents a calculated move to channel artificial intelligence toward clinical efficiency rather than mere revenue generation.